FDA approves IMAAVY® (nipocalimab-aahu) as first-ever treatment for warm autoimmune ...

Reports

11

Domains carrying it

11

First reported

24 August 2026

Latest report

1 September 2026

◆ Sectors

◆ Where

United States

◆ Timeline

1. 24 August 2026FDA approves IMAAVY® (nipocalimab-aahu) as first-ever treatment for warm autoimmune ...jnj.com
2. 25 August 2026Johnson & Johnson Gets FDA Approval for Imaavy to Treat Warm Autoimmune Hemolytic Anemiamarketwatch.com
3. 1 September 2026IMAVVY approved as first targeted therapy for wAIHApharmatimes.com

◆ Connected developments

Situations Wire finds semantically close to this one. Proximity, not cause.

• FDA Approves Ropeginterferon Alfa-2b for Essential Thrombocythemia11 reports · 10 domains · 2 September 2026
• US FDA expands approval for J&J's drug for rare blood disorder2 reports · 2 domains · 25 August 2026
• FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder14 reports · 12 domains · 1 September 2026
• U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb's First CELMoD Therapy ...12 reports · 12 domains · 17 August 2026
• US FDA approves Takeda, Protagonist's drug for rare blood cancer3 reports · 3 domains · 1 September 2026
• FDA Grants Accelerated Approval to Iberdomide Combination for Relapsed or Refractory ...3 reports · 3 domains · 13 August 2026

◆ Share

◆ Evidence

11 reports · 11 domains

• IMAVVY approved as first targeted therapy for wAIHApharmatimes.com · 1 September 2026
• FDA Approves Nipocalimab-aahu as First Treatment for wAIHAajmc.com · 25 August 2026
• FDA Approves First Drug for Warm Autoimmune Hemolytic Anemiafda.gov · 25 August 2026
• FDA Approves Nipocalimab for Warm Autoimmune Hemolytic Anemiapharmacytimes.com · 25 August 2026
• FDA Approves First Treatment for Warm Autoimmune Hemolytic Anemiahcplive.com · 25 August 2026
• FDA Approves IMAAVY (Nipocalimab) for Warm Autoimmune Hemolytic Anemiaclinicaltrialvanguard.com · 25 August 2026
• US FDA expands approval for J&J's drug for rare blood disorderwhbl.com · 25 August 2026
• Johnson & Johnson Gets FDA Approval for Imaavy to Treat Warm Autoimmune Hemolytic Anemiamarketwatch.com · 25 August 2026
• FDA approves IMAAVY® (nipocalimab-aahu) as first-ever treatment for warm autoimmune ...prnewswire.com · 24 August 2026
• US FDA expands approval for J&J's drug for rare blood disorderwtvbam.com · 24 August 2026
• FDA approves IMAAVY® (nipocalimab-aahu) as first-ever treatment for warm autoimmune ...jnj.com · 24 August 2026